Premium Nahrungsergänzungsmittel | artgerecht

Umbilical Cord Blood: Stem Cells, Donation & Banking

Umbilical cord blood is the blood remaining in the umbilical cord and placenta after birth. It is rich in stem cells and used in medical treatments such as stem cell transplantation.

Regular tips about health Regular tips about health

Things worth knowing about "Umbilical cord blood"

Umbilical cord blood is the blood remaining in the umbilical cord and placenta after birth. It is rich in stem cells and used in medical treatments such as stem cell transplantation.

What is Umbilical Cord Blood?

Umbilical cord blood is the blood that remains in the umbilical cord and placenta (afterbirth) following the delivery of a baby. This blood is especially valuable because it contains a high concentration of hematopoietic stem cells – cells capable of developing into all types of blood cells. Normally, the umbilical cord is clamped and cut after birth and the remaining blood is discarded. However, through a targeted collection process, it can be preserved and used for medical purposes.

Composition and Special Properties

Umbilical cord blood differs from regular adult blood in several important ways:

High stem cell content: It contains significantly more blood-forming stem cells than adult peripheral blood.
Lower immunoreactivity: The immune cells in cord blood are less aggressive, reducing the risk of graft-versus-host disease (GvHD) following transplantation.
Easy collection: The collection process is painless and risk-free for both mother and child, as it takes place after delivery.
Long-term storage: Cord blood can be cryogenically stored at –196 °C in liquid nitrogen for several decades.

Collection and Banking

Umbilical cord blood is collected immediately after birth and after the cord has been clamped and cut. The blood drains into a sterile collection bag by gravity. The procedure takes only a few minutes and is completely painless. The sample is then processed in a laboratory and frozen for storage. There are two main forms of cord blood banking:

Public cord blood banks: The blood is donated and made available to any compatible patient worldwide. This option is free of charge and is considered medically most valuable, as it increases the availability of stem cell donations for patients in need.
Private cord blood banks: The blood is stored exclusively for the child or family. This involves ongoing fees, and the statistical likelihood that the stored blood will ever be needed is relatively low.

Medical Applications

Cord blood stem cell transplants have been used in medicine since the late 1980s. The main areas of application include:

Leukemias: Various forms of blood cancer, such as acute myeloid leukemia (AML) or acute lymphoblastic leukemia (ALL), can be treated with cord blood stem cell transplantation.
Lymphomas: Malignant diseases of the lymphatic system, such as Hodgkin lymphoma and non-Hodgkin lymphoma.
Bone marrow failure: Conditions such as aplastic anemia, where the bone marrow can no longer produce sufficient blood cells.
Inherited metabolic disorders: Certain rare conditions such as mucopolysaccharidoses can be addressed through stem cell transplantation.
Immune deficiencies: Congenital immunodeficiencies requiring reconstruction of the immune system through new stem cells.

Current State of Research

Research surrounding cord blood is continuously advancing. Scientists are investigating the use of cord blood stem cells in regenerative medicine, including potential applications in neurological conditions such as cerebral palsy and autism spectrum disorder. However, these applications remain largely experimental and are not yet part of standard clinical care. Research into mesenchymal stem cells derived from the Wharton jelly – the gelatinous connective tissue of the umbilical cord – is also ongoing.

Recommendations from Medical Societies

Leading medical organizations, including the American Academy of Pediatrics (AAP) and the European Blood and Marrow Transplantation Group (EBMT), recommend public donation of cord blood when there is no specific family medical indication. Routine private banking without a concrete medical need is generally not recommended by most professional societies, as the probability of personal use remains very low.

References

Gluckman E. et al. - Hematopoietic reconstitution in a patient with Fanconi anemia by means of umbilical-cord blood from an HLA-identical sibling. New England Journal of Medicine, 1989.
American Academy of Pediatrics (AAP) - Policy Statement on Cord Blood Banking for Potential Future Transplantation, 2017.
World Health Organization (WHO) - Stem cell transplantation and cord blood banking: current status and perspectives, 2020.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.